SEROPREVALENCE OF VIRAL HEPATITIS A, B, C, AND E MARKERS IN UROLOGICAL PATIENTS
DOI:
https://doi.org/10.5281/zenodo.8213208Keywords:
seroprevalence, markers, viral hepatitis, urological patientsAbstract
Objectives. Emphasizing the importance of periodic testing for viral hepatitis markers in urology patients as a crucial measure for proper infection management.
Methods. A cross-sectional descriptive epidemiological study was conducted. Blood samples were collected from patients in the urology department of the Republican Clinical Hospital and examined using enzyme-linked immunosorbent assay (ELISA) for the following viral hepatitis markers: anti-HAV, anti-HAV IgM, AgHBs, anti-HBcor, anti-HBs, anti-HCV, anti-HEV IgG and anti-HEV IgM. A total of 234 patients were examined, and 1638 laboratory tests were performed.
Results. The following seroprevalence levels of viral hepatitis markers were identified among patients in the urology department of”Timofei Moșneaga” Republican Clinical Hospital: AgHBs – 9.0±1.9%; anti-HBcor –47.9±3.3%; anti-HBs – 41.0±3.2%; anti-HCV – 7.7±1.7%; anti-HAV – 95.3±1.4%; anti-HAV IgM – 0%; anti-HEV IgG – 17.5±2.5%; anti-HEV IgM – 27.4±2.9%. The most affected groups for hepatitis B and C were females from the central region of the country, while for hepatitis E – males from the northern region were the most affected.
Conclusions. The results indicate that urological patients can be considered a group at increased risk of infection with hepatitis B, C, and E viruses.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Arta Medica

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.